Humphreys Benjamin D
Renal Division, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA ; Harvard Stem Cell Institute , Cambridge, Massachusetts, USA.
Kidney Int Suppl (2011). 2011 Sep;1(3):83-86. doi: 10.1038/kisup.2011.19.
Developing new therapeutic approaches to treat acute kidney injury requires a detailed understanding of endogenous cellular repair. Genetic fate mapping defines cellular hierarchies and we used this technique to assess a possible contribution of non-epithelial stem cells to renal repair after ischemic injury. Mice with efficient labeling of renal epithelial cells, but not non-epithelial interstitial cells, were subjected to a single cycle or sequential cycles of kidney injury and repair. No dilution of the epithelial cell fate marker was observed despite robust epithelial cell proliferation. Thus, non-tubular cells do not have the ability to migrate across the basement membrane and differentiate into epithelial cells in this model. Instead, surviving tubular epithelial cells are responsible for repair of the damaged nephron. Future studies will need to distinguish between uniform dedifferentiation and proliferation of all epithelial cells after injury versus selective expansion of an intratubular epithelial stem cell.
开发治疗急性肾损伤的新治疗方法需要对内源性细胞修复有详细的了解。遗传命运图谱定义了细胞层次结构,我们使用该技术评估非上皮干细胞对缺血性损伤后肾脏修复的可能贡献。对肾上皮细胞进行有效标记但未对非上皮间质细胞进行标记的小鼠,经历了单次或连续的肾损伤和修复周期。尽管上皮细胞大量增殖,但未观察到上皮细胞命运标记的稀释。因此,在该模型中,非肾小管细胞没有跨越基底膜迁移并分化为上皮细胞的能力。相反,存活的肾小管上皮细胞负责受损肾单位的修复。未来的研究需要区分损伤后所有上皮细胞的均匀去分化和增殖与肾小管内上皮干细胞的选择性扩增。